NO20080890L - Sammensetninger for a redusere forekomsten av medikamentindusert arytmi - Google Patents
Sammensetninger for a redusere forekomsten av medikamentindusert arytmiInfo
- Publication number
- NO20080890L NO20080890L NO20080890A NO20080890A NO20080890L NO 20080890 L NO20080890 L NO 20080890L NO 20080890 A NO20080890 A NO 20080890A NO 20080890 A NO20080890 A NO 20080890A NO 20080890 L NO20080890 L NO 20080890L
- Authority
- NO
- Norway
- Prior art keywords
- drug
- compositions
- methods
- incidence
- reduce
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 5
- 239000003814 drug Substances 0.000 title abstract 3
- 229940079593 drug Drugs 0.000 title abstract 3
- 206010003119 arrhythmia Diseases 0.000 title abstract 2
- 230000006793 arrhythmia Effects 0.000 title 1
- 238000000034 method Methods 0.000 abstract 3
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 abstract 2
- MREBEPTUUMTTIA-PCLIKHOPSA-N Azimilide Chemical compound C1CN(C)CCN1CCCCN1C(=O)N(\N=C\C=2OC(=CC=2)C=2C=CC(Cl)=CC=2)CC1=O MREBEPTUUMTTIA-PCLIKHOPSA-N 0.000 abstract 2
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 abstract 2
- 208000018452 Torsade de pointes Diseases 0.000 abstract 2
- 208000002363 Torsades de Pointes Diseases 0.000 abstract 2
- 229960001138 acetylsalicylic acid Drugs 0.000 abstract 2
- 239000003416 antiarrhythmic agent Substances 0.000 abstract 2
- 229950001786 azimilide Drugs 0.000 abstract 2
- 238000009472 formulation Methods 0.000 abstract 2
- 239000000935 antidepressant agent Substances 0.000 abstract 1
- 229940005513 antidepressants Drugs 0.000 abstract 1
- 229940125715 antihistaminic agent Drugs 0.000 abstract 1
- 239000000739 antihistaminic agent Substances 0.000 abstract 1
- 239000004599 antimicrobial Substances 0.000 abstract 1
- 239000000164 antipsychotic agent Substances 0.000 abstract 1
- 239000002934 diuretic Substances 0.000 abstract 1
- 229940030606 diuretics Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/401—Proline; Derivatives thereof, e.g. captopril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
- A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/724—Cyclodextrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Toxicology (AREA)
- Cardiology (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US70155505P | 2005-07-22 | 2005-07-22 | |
| PCT/IB2006/052496 WO2007010498A2 (en) | 2005-07-22 | 2006-07-20 | Compositions for reducing the incidence of drug induced arrhythmia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20080890L true NO20080890L (no) | 2008-03-03 |
Family
ID=37547445
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20080890A NO20080890L (no) | 2005-07-22 | 2008-02-21 | Sammensetninger for a redusere forekomsten av medikamentindusert arytmi |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US8183284B2 (ja) |
| EP (1) | EP1906966A2 (ja) |
| JP (1) | JP4880685B2 (ja) |
| KR (1) | KR20080017489A (ja) |
| CN (1) | CN101227908A (ja) |
| AR (1) | AR055091A1 (ja) |
| AU (1) | AU2006271230A1 (ja) |
| BR (1) | BRPI0613670A2 (ja) |
| CA (1) | CA2615975C (ja) |
| IL (1) | IL188831A0 (ja) |
| MA (1) | MA29622B1 (ja) |
| MX (1) | MX2008001063A (ja) |
| NO (1) | NO20080890L (ja) |
| PE (1) | PE20070369A1 (ja) |
| RU (1) | RU2376994C2 (ja) |
| SM (1) | SMP200800012B (ja) |
| TW (1) | TW200744613A (ja) |
| WO (1) | WO2007010498A2 (ja) |
| ZA (1) | ZA200800564B (ja) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105534976A (zh) * | 2016-01-14 | 2016-05-04 | 山东大学 | 2-(2,2-二苯基环丙基)-4,5-二氢-1h-咪唑在制备抗神经退化性疾病药物中的应用 |
| US10890577B2 (en) * | 2016-05-19 | 2021-01-12 | Tabula Rasa Healthcare, Inc. | Treatment methods having reduced drug-related toxicity and methods of identifying the likelihood of patient harm from prescribed medications |
| WO2018124236A1 (ja) * | 2016-12-27 | 2018-07-05 | 国立大学法人大阪大学 | 難治性心疾患治療用医薬組成物 |
| JP2022506440A (ja) * | 2018-11-02 | 2022-01-17 | セルトリオン， インク． | 肥大型心筋症治療用薬学組成物 |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB742544A (en) | 1952-02-23 | 1955-12-30 | Kodak Ltd | Enteric products |
| FR2833M (ja) | 1962-06-12 | 1964-10-05 | I N I C O Ind Nuclear Invest C | |
| GB1142757A (en) | 1967-01-26 | 1969-02-12 | Carter Wallace | Therapeutic compositions |
| GB1269181A (en) | 1969-03-24 | 1972-04-06 | Monsanto Co | Effervescent compositions |
| US3887700A (en) | 1969-11-28 | 1975-06-03 | Aspro Nicholas Ltd | Analgesic formulations |
| BE759520A (fr) | 1969-11-28 | 1971-04-30 | Aspro Nicholas Ltd | Compositions d'aspirine |
| JPS58126879A (ja) | 1982-01-25 | 1983-07-28 | Nippon Chemiphar Co Ltd | 光学活性なピペラジン誘導体ならびに心筋梗塞の予防および治療剤 |
| US4783443A (en) | 1986-03-03 | 1988-11-08 | The University Of Chicago | Amino acyl cephalosporin derivatives |
| WO1990009185A1 (en) | 1989-02-16 | 1990-08-23 | Angio-Medical Corp. | Composition and method for treatment of gastric and duodenal ulcers and mucosal erosions |
| GB9104854D0 (en) | 1991-03-07 | 1991-04-17 | Reckitt & Colmann Prod Ltd | Sustained release compositions |
| JP3228347B2 (ja) | 1991-06-25 | 2001-11-12 | 三菱化学株式会社 | シクロプロペノン誘導体 |
| ATE171171T1 (de) | 1992-12-25 | 1998-10-15 | Mitsubishi Chem Corp | Alpha-aminoketon derivate |
| US6316487B1 (en) * | 1993-06-16 | 2001-11-13 | Aryx Therapeutics | Compounds for treatment of cardiac arrhythmia synthesis, and methods of use |
| EP0821587A4 (en) | 1995-04-19 | 1999-05-19 | Lipoprotein Technologies Inc | COMPOSITIONS, KITS AND METHODS FOR ADMINISTERING ANTILIPEMICS AND MEDICINES AGAINST PLATELET AGGREGATION |
| TWI238064B (en) | 1995-06-20 | 2005-08-21 | Takeda Chemical Industries Ltd | A pharmaceutical composition for prophylaxis and treatment of diabetes |
| ATE305301T1 (de) | 1996-11-05 | 2005-10-15 | Childrens Medical Center | Mittel zur hemmung von angiogenese enthaltend thalodomid und einen nsaid |
| US6245797B1 (en) | 1997-10-22 | 2001-06-12 | Merck & Co., Inc. | Combination therapy for reducing the risks associated with cardio-and-cerebrovascular disease |
| US6884792B2 (en) | 1999-01-08 | 2005-04-26 | Marvin B. Bacaner | Bretylium compositions and kits and their use in preventing and treating cardiovascular conditions |
| EP1140054B1 (en) | 1999-01-08 | 2005-03-16 | Marvin B. Bacaner | Bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions |
| AU2003226148A1 (en) | 2002-04-05 | 2003-10-27 | Merck & Co., Inc. | Method for inhibiting bone resorption with an alendronate and vitamin d formulation |
| FR2838057B1 (fr) | 2002-04-05 | 2005-07-08 | Servier Lab | Nouvelle association d'un antithrombotique et d'aspirine |
| EP1501546B1 (de) | 2002-05-03 | 2012-10-10 | Hexal AG | Stabile pharmazeutische formulierung für eine kombination aus einem statin mit einem ace-hemmer |
| AU2003248786A1 (en) | 2002-07-03 | 2004-01-23 | Esperion Therapeutics, Inc. | Compositions comprising panthetine for the treatment of dyslipidemia |
| US20050142129A1 (en) | 2002-10-15 | 2005-06-30 | Mangano Dennis T. | Methods of preventing morbidity and mortality by perioperative administration of a blood clotting inhibitor |
| WO2005018635A2 (en) | 2003-08-07 | 2005-03-03 | Cardiome Pharma Corp. | Ion channel modulating activity i |
| PE20050438A1 (es) | 2003-10-20 | 2005-06-14 | Esperion Therapeutics Inc | Formulas farmaceuticas, metodos y regimenes de dosificacion para el tratamiento y la prevencion de sindromes coronarios agudos |
-
2006
- 2006-07-20 CN CNA200680026609XA patent/CN101227908A/zh active Pending
- 2006-07-20 AU AU2006271230A patent/AU2006271230A1/en not_active Abandoned
- 2006-07-20 EP EP06780154A patent/EP1906966A2/en not_active Withdrawn
- 2006-07-20 KR KR1020087001549A patent/KR20080017489A/ko active IP Right Grant
- 2006-07-20 CA CA2615975A patent/CA2615975C/en not_active Expired - Fee Related
- 2006-07-20 MX MX2008001063A patent/MX2008001063A/es unknown
- 2006-07-20 BR BRPI0613670-2A patent/BRPI0613670A2/pt not_active IP Right Cessation
- 2006-07-20 JP JP2008522160A patent/JP4880685B2/ja not_active Expired - Fee Related
- 2006-07-20 SM SM200800012T patent/SMP200800012B/it unknown
- 2006-07-20 WO PCT/IB2006/052496 patent/WO2007010498A2/en active Application Filing
- 2006-07-20 US US11/489,756 patent/US8183284B2/en not_active Expired - Fee Related
- 2006-07-20 RU RU2007148908/15A patent/RU2376994C2/ru not_active IP Right Cessation
- 2006-07-21 AR ARP060103156A patent/AR055091A1/es unknown
- 2006-07-21 PE PE2006000884A patent/PE20070369A1/es not_active Application Discontinuation
- 2006-07-21 TW TW095126806A patent/TW200744613A/zh unknown
-
2008
- 2008-01-09 MA MA30561A patent/MA29622B1/fr unknown
- 2008-01-17 IL IL188831A patent/IL188831A0/en unknown
- 2008-01-17 ZA ZA200800564A patent/ZA200800564B/xx unknown
- 2008-02-21 NO NO20080890A patent/NO20080890L/no not_active Application Discontinuation
-
2012
- 2012-03-22 US US13/427,458 patent/US20120178724A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| IL188831A0 (en) | 2008-08-07 |
| US8183284B2 (en) | 2012-05-22 |
| CA2615975A1 (en) | 2007-01-25 |
| CA2615975C (en) | 2012-11-27 |
| PE20070369A1 (es) | 2007-05-16 |
| MX2008001063A (es) | 2008-03-19 |
| BRPI0613670A2 (pt) | 2011-01-25 |
| US20120178724A1 (en) | 2012-07-12 |
| WO2007010498A2 (en) | 2007-01-25 |
| SMAP200800012A (it) | 2008-02-27 |
| TW200744613A (en) | 2007-12-16 |
| JP2009502773A (ja) | 2009-01-29 |
| RU2376994C2 (ru) | 2009-12-27 |
| ZA200800564B (en) | 2008-12-31 |
| EP1906966A2 (en) | 2008-04-09 |
| RU2007148908A (ru) | 2009-08-27 |
| SMP200800012B (it) | 2008-02-27 |
| AR055091A1 (es) | 2007-08-08 |
| US20070021395A1 (en) | 2007-01-25 |
| JP4880685B2 (ja) | 2012-02-22 |
| WO2007010498A3 (en) | 2007-05-31 |
| CN101227908A (zh) | 2008-07-23 |
| AU2006271230A1 (en) | 2007-01-25 |
| KR20080017489A (ko) | 2008-02-26 |
| MA29622B1 (fr) | 2008-07-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20081843L (no) | Farmasoytisk sammensetning for forbedret kognitiv funksjon | |
| NO20055863L (no) | W-karboksyarylsubstituerte difenylureaforbindelser som raf-kinaseinhibitorer | |
| BR0212042A (pt) | Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, e, uso de um composto | |
| NO20082673L (no) | Nye 2-amino-imidazol-4-on forbindelser og deres anvendelse i fremstilling av et medikament som skal brukes til behandling av kognitiv svekkelse, Alzheimers sykdom, neurodegenerasjon og demens | |
| CL2004001174A1 (es) | Composicion farmaceutica que comprende: 1-(4-fluorofenil)-3(r)-[3-(4-fluorofenil)-3(s)-hidroxipropil]-4(s)-(4-hidroxifenil)-2-acetidinona (ezetimiba) y excipientes; y su uso en el tratamiento y/o prevencion de aterosclerosis, hipercolesterolemia, dia | |
| NO20064347L (no) | Substituerte 1,2,3,4-tetrahydroisokinolinderivater | |
| CL2003002731A1 (es) | Compuesto derivado de quinazolina de formula definida, que actua como inhibidor de la kinasa aurora; procedimiento de preparacion del compuesto; composicion farmaceutica que comprende al compuesto y uso del compuesto; util para el tratamiento de enfe | |
| NO20052739L (no) | CCR5-antagonister som medikamenter | |
| UY28931A1 (es) | Derivados de pirrolotriazina utiles para tratar trastornos hiper-proliferativos y enfermedades asociadas con angiogenesis | |
| MA28748B1 (fr) | Applications galeniques de melanges auto-emulsionnants d'excipients lipidiques | |
| BR0215184A (pt) | composições farmacêuticas de derivados de taxano oralmente ativos tendo biodisponibilidade aumentada | |
| NO20025601D0 (no) | Arylmetylaminderivater for anvendelse som tryptaseinhibitorer | |
| BRPI0416752A (pt) | composição farmacêutica, uso de um ou mais compostos, método para a prevenção ou tratamento de distúrbios, compostos, e, processo para a preparação de uma composição farmacêutica | |
| TW200615266A (en) | Organic compounds | |
| NO20063449L (no) | Substituerte heterocykler og deres anvendelse | |
| CO5251419A1 (es) | Composiciones nanoparticuladas de eplerenona | |
| ECSP055701A (es) | Nuevos derivados de pirimidinamida y el uso de los mismos | |
| EA200701113A1 (ru) | Макролиды | |
| ES2328496T3 (es) | Compuestos de 1,4,8-triaza-espiro(4,5)decan-2-ona sustituidos. | |
| DK1296972T3 (da) | Arylmethylamin-derivater til anvendelse som tryptaseinhibitorer | |
| NO20080890L (no) | Sammensetninger for a redusere forekomsten av medikamentindusert arytmi | |
| BR0111868A (pt) | Composições farmacêuticas | |
| CL2007000789A1 (es) | Compuestos derivados de malonamida, inhibidores de la gamma-secretasa; proceso de preparacion; composicion farmaceutica; y su uso en el tratamiento de la enfermedad de alzheimer. | |
| NO20076405L (no) | Anvendelse av 24-nor-UDCA | |
| ATE505464T1 (de) | Feste form von amg 706 und pharmazeutische zusammensetzungen davon |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |